GlassScriptPhysician profile
John L Moseri
NPI 1346253309
$1,000.10
in general payments reported to CMS, 2019-2025
12 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Addiction Psychiatry provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $54.16 · 2021: $112 · 2022: $46.52 · 2023: $57.43 · 2024: $249 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $196.64 | 2019-2024 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $193.78 | 2021-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $140.07 | 2022-2025 | Invega Sustenna |
| Abbvie INC. | $109.36 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $89.26 | 2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $74.59 | 2024-2025 | Uzedy |
| Otsuka America Pharmaceutical, INC. | $59.06 | 2019-2024 | Abilify Maintena, Rexulti |
| Brainsway USA INC | $44.70 | 2024 | Brainsway Deep Tms System |
| Indivior INC. | $29.70 | 2020 | |
| Alkermes, INC. | $23.79 | 2019 | |
| Lundbeck LLC | $20.21 | 2019 | |
| Masimo Corporation | $18.94 | 2023 | Emma and Isa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moseri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.